MedTrace Logo

A Comparison of One Versus Two Doses of Influenza Vaccine in Children 5-8 Years of Age

NCT00158665 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2017-10-13

No results posted yet for this study

Summary

The purpose of the study was to find out if children 5 through 8 years of age who are getting influenza vaccine for the first time should get one or two doses.

Conditions

Interventions

BIOLOGICAL

2 0.5 ml doses of '04-05 Trivalent Influenza Vaccine

2 0.5 ml doses of '04-05 Trivalent Influenza Vaccine

Sponsors & Collaborators

Principal Investigators

  • Lisa A Jackson, MD, MPH · Kaiser Permanente

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2004-12-31
Completion
2004-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00158665 on ClinicalTrials.gov